title: PET studies of net blood-brain clearance of FDOPA to human brain: age-dependent decline of [18F]fluorodopamine storage capacity.
abstract: Conventional methods for the graphical analysis of 6-[(18)F]fluorodopa (FDOPA)/positron emission tomography (PET) recordings (K(in)(app)) may be prone to negative bias because of oversubtraction of the precursor pool in the region of interest, and because of diffusion of decarboxylated FDOPA metabolites from the brain. These effects may reduce the sensitivity of FDOPA/PET for the detection of age-related changes in dopamine innervations. To test for these biasing effects, we have used a constrained compartmental analysis to calculate the brain concentrations of the plasma metabolite 3-O-methyl-FDOPA (OMFD) during 120 mins of FDOPA circulation in healthy young, healthy elderly, and Parkinson's disease subjects. Calculated brain OMFD concentrations were subtracted frame-by-frame from the dynamic PET recordings, and maps of the FDOPA net influx to brain were calculated assuming irreversible trapping (K(app)). Comparison of K(in)(app) and K(app) maps revealed a global negative bias in the conventional estimates of FDOPA clearance. The present OMFD subtraction method revealed curvature in plots of K(app) at early times, making possible the calculation of the corrected net influx (K) and also the rate constant for diffusion of decarboxylated metabolites from the brain (k(loss)). The effective distribution volume (EDV(2); K/k(loss)) for FDOPA, an index of dopamine storage capacity in brain, was reduced by 85% in putamen of patients with Parkinson's disease, and by 58% in the healthy elderly relative to the healthy young control subjects. Results of the present study support claims that storage capacity for dopamine in both caudate and putamen is more profoundly impaired in patients with Parkinson's disease than is the capacity for DOPA utilization, calculated by conventional FDOPA net influx plots. The present results furthermore constitute the first demonstration of an abnormality in the cerebral utilization of FDOPA in caudate and putamen as a function of normal aging, which we attribute to loss of vesicular storage capacity.
authors.affiliation: PET Centre, Aarhus University Hospitals, Aarhus, Denmark. yoshi@pet.auh.dk
authors.forename: Yoshitaka
authors.initials: Y
authors.lastname: Kumakura
authors.forename: Ingo
authors.initials: I
authors.lastname: Vernaleken
authors.forename: Gerhard
authors.initials: G
authors.lastname: Gründer
authors.forename: Peter
authors.initials: P
authors.lastname: Bartenstein
authors.forename: Albert
authors.initials: A
authors.lastname: Gjedde
authors.forename: Paul
authors.initials: P
authors.lastname: Cumming
mesh_terms: D000328:Adult; D000375:Aging / Q000502:physiology; D001921:Brain / Q000098:blood supply* / Q000378:metabolism*; D004058:Diffusion; D004295:Dihydroxyphenylalanine / Q000031:analogs & derivatives* / Q000378:metabolism* / Q000493:pharmacokinetics*; D005462:Fluorine Radioisotopes; D006801:Humans; D008875:Middle Aged; D049268:Positron-Emission Tomography
chemical_list: D005462:Fluorine Radioisotopes; C043437:fluorodopa F 18; D004295:Dihydroxyphenylalanine